Plus   Neg

Kenmare Resources Says Achieved Or Exceeded Midpoint Of Finished Products Guidance Ranges

Kenmare Resources plc. (KMR.L), in its trading update for the fourth quarter and the full year ended 31 December 2020, said that it achieved or exceeded the midpoint of its August 2020 guidance ranges for all finished products. It targets an uplift of ilmenite production in 2021 of between approximately 45% and 60%. In addition to higher revenues, increased production will deliver lower unit costs.

In the fourth-quarter 2020, Kenmare produced 219,100 tonnes of ilmenite, a 7% increase from last year.

Total shipments of finished products in fiscal year 2020 were 853,100 tonnes, a 17% decrease from the prior year, impacted by adverse weather conditions during a significant portion of the year and reduced availability of the transhipment vessels, which underwent works to increase capacity. Shipments were comprised of 766,500 tonnes of ilmenite, 43,100 tonnes of primary zircon, 6,300 tonnes of rutile and 37,200 tonnes of concentrates.

The company expects production of all finished products for fiscal year 2021 to be higher than in fiscal year 2020, due primarily to WCP B mining higher grade ore in Pilivili. Ilmenite production in 2021 is expected to be 1.1 million to 1.2 million tonnes, building towards 1.2 million tonnes per annum on a consistent basis.
QKenmare will release its 2020 Preliminary Results on Wednesday 24 March 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Chico's FAS Inc. (CHS) Tuesday reported a wider year-over-year net loss for the fourth quarter. Meanwhile, Kohl's Corp.'s (KSS) fourth-quarter net income grew 29 percent from the previous year. But Abercrombie & Fitch Co.'s (ANF) fourth-quarter net income decreased 1 percent from the prior year. The U.S. Food and Drug Administration has approved the marketing of a new robotically-assisted surgical device (RASD) that can facilitate transvaginal hysterectomy in certain patients using minimally-invasive surgical instruments. The Hominis Surgical System of Memic Innovative Surgery Ltd., the U.S. subsidiary of Israeli biotechnology company memic Ltd., has been granted marketing authorization. Canadian cannabis company Canopy Growth Corp. (CGC, WEED.TO) announced Tuesday the launch of its Cannabidiol (CBD) beverage brand Quatreau in the high-potential U.S. market. Quatreau will be sold on Canopy's one-stop U.S. e-commerce destination, www.shopcanopy.com. Quatreau is a premium ready-to-drink...
Follow RTT